Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Products > On-Demand Supplier Webinar

Vitamin K2 Going Mass Market. The Experts Discuss: Successful Product Launches

Format: Webinar | Document type: Supplier Webinar
Kappa Biosciences

The unparalleled bone and heart benefits of vitamin K2 MK-7 have opened doors to mass market consumers. More and more K2 products are being launched, with companies and marketers looking to gain first-mover advantage.

Join Kappa Bioscience and a panel of industry experts who will discuss and answer questions about launching successful K2 products.

The roundtable discussion and Q&A will cover:

  • K2 science 
  • Market opportunity 
  • Commercial risks
  • Formulation
  • Galenics
  • Stability and quality
  • Analysis

K2 is ready for mass markets. Join us to learn how to profit from the enormous potential of vitamin K2 MK-7.


  • Bjarne Bloch

    Bjarne Bloch

    Medical Advisor

    Orkla Care A/S

  • Dr. Juergen Wolf

    Dr. Juergen Wolf

    General Manager

    K2 MedicalCare GmbH

  • Egil Greve

    Egil Greve

    President & CEO

    Kappa Bioscience

  • Francis Foley

    Francis Foley


    Xsto Solutions

  • Jim Bornhold

    Jim Bornhold

    Executive VP of Nutraceuticals

    Chemroy Canada Inc.

  • Jörg Büttinghaus

    Jörg Büttinghaus

    Vice President Sales & Marketing

    Kappa Bioscience

  • Morgan Laloux

    Morgan Laloux

    Business Development Manager Health and Nutrition Southern Europe


  • Scott Colbourne

    Scott Colbourne

    Business Manager NSW, Food & Pharmaceutical

    ALS Pharmaceutical Australia

  • Virpi	Varjonen

    Virpi Varjonen


    Invenire Market Intelligence Oy

Related Resources from Kappa Bioscience & XSTO Solutions